ImmunoPrecise Antibodies Ltd. - Common Stock (IPA)
0.4050
0.00 (0.00%)
Immunoprecise Antibodies Ltd is a biotechnology company that specializes in the development and production of high-quality antibodies and related therapeutics for use in various biomedical applications
The company offers a range of services, including custom antibody production, protein engineering, and diagnostic assay development, catering to the needs of researchers and pharmaceutical companies. With a focus on advancing personalized medicine and supporting drug discovery, Immunoprecise Antibodies aims to provide innovative solutions that enhance the effectiveness of therapeutic treatments across multiple disease areas.

Via Benzinga · March 14, 2025

As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · March 13, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · March 13, 2025

ImmunoPrecise announced a partnership with a biotechnology giant to develop ADCs and bispecific antibodies for the treatment of cancer.
Via Benzinga · March 13, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · February 26, 2025

Immunoprecise shares closed higher on Wednesday after the company announced it developed a new class of GLP-1 therapies.
Via Benzinga · January 22, 2025

Via Benzinga · January 22, 2025

Via Benzinga · January 22, 2025

Via Benzinga · January 22, 2025

ImmunoPrecise Antibodies launches BioStrand's LENSaiAPI software, enhancing AI-driven drug discovery and data integration for healthcare and pharmaceutical industries.
Via Benzinga · June 10, 2024

Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with precise, scalable data analysis.
Via Benzinga · March 28, 2024

IPA stock results show that ImmunoPrecise Antibodies missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Via InvestorPlace · March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQPHAR) is projected to report earnings for its fourth quarter.
Via Benzinga · March 14, 2024

Shares of HighPeak Energy, Inc. (NASDAQHPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via Benzinga · March 7, 2024

Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly different meanings depending on their context.
Via Benzinga · February 12, 2024

ImmunoPrecise Antibodies (NASDAQIPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently
Via Benzinga · January 9, 2024

IPA stock results show that ImmunoPrecise Antibodies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · December 14, 2023

Companies Reporting Before The Bell • Live Ventures (NASDAQLIVE) is estimated to report earnings for its fourth quarter. • Jabil NYSE:JBLNYSEJBL)
Via Benzinga · December 14, 2023

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
Via Benzinga · December 6, 2023